UBS AM’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-61,913
| Closed | -$642K | – | 2798 |
|
|
2022
Q2 | $642K | Sell |
61,913
-215
| -0.3% | -$1.6K | ﹤0.01% | 2188 |
|
|
2022
Q1 | $549K | Hold |
62,128
| – | – | ﹤0.01% | 2432 |
|
|
2021
Q4 | $430K | Sell |
62,128
-1,665
| -3% | -$24.4K | ﹤0.01% | 2607 |
|
|
2021
Q3 | $792K | Buy |
63,793
+9,563
| +18% | +$138K | ﹤0.01% | 2283 |
|
|
2021
Q2 | $989K | Buy |
54,230
+3,390
| +7% | +$67.4K | ﹤0.01% | 2221 |
|
|
2021
Q1 | $1.06M | Buy |
50,840
+10,822
| +27% | +$228K | ﹤0.01% | 2060 |
|
|
2020
Q4 | $715K | Hold |
40,018
| – | – | ﹤0.01% | 2147 |
|
|
2020
Q3 | $454K | Sell |
40,018
-9,378
| -19% | -$116K | ﹤0.01% | 2184 |
|
|
2020
Q2 | $673K | Buy |
49,396
+17,743
| +56% | +$244K | ﹤0.01% | 1983 |
|
|
2020
Q1 | $411K | Sell |
31,653
-9,864
| -24% | -$176K | ﹤0.01% | 2047 |
|
|
2019
Q4 | $837K | Buy |
41,517
+165
| +0.4% | +$4.01K | ﹤0.01% | 2006 |
|
|
2019
Q3 | $1.06M | Buy |
41,352
+19,952
| +93% | +$489K | ﹤0.01% | 1914 |
|
|
2019
Q2 | $521K | Hold |
21,400
| – | – | ﹤0.01% | 2194 |
|
|
2019
Q1 | $427K | Buy |
21,400
+1,900
| +10% | +$34.7K | ﹤0.01% | 2169 |
|
|
2018
Q4 | $322K | Hold |
19,500
| – | – | ﹤0.01% | 2184 |
|
|
2018
Q3 | $347K | Hold |
19,500
| – | – | ﹤0.01% | 2233 |
|
|
2018
Q2 | $575K | Sell |
19,500
-5,893
| -23% | -$186K | ﹤0.01% | 2038 |
|
|
2018
Q1 | $913K | Buy |
25,393
+4,113
| +19% | +$149K | ﹤0.01% | 1820 |
|
|
2017
Q4 | $676K | Buy |
21,280
+6,315
| +42% | +$198K | ﹤0.01% | 1872 |
|
|
2017
Q3 | $577K | Buy |
14,965
+839
| +6% | +$32.9K | ﹤0.01% | 1896 |
|
|
2017
Q2 | $639K | Buy |
14,126
+5,926
| +72% | +$226K | ﹤0.01% | 1810 |
|
|
2017
Q1 | $317K | Hold |
8,200
| – | – | ﹤0.01% | 1993 |
|
|
2016
Q4 | $312K | Sell |
8,200
-14,371
| -64% | -$684K | ﹤0.01% | 1934 |
|
|
2016
Q3 | $1.22M | Buy |
22,571
+2,543
| +13% | +$129K | ﹤0.01% | 1599 |
|
|
2016
Q2 | $736K | Buy |
20,028
+6,428
| +47% | +$227K | ﹤0.01% | 1781 |
|
|
2016
Q1 | $428K | Sell |
13,600
-4,542
| -25% | -$157K | ﹤0.01% | 2009 |
|
|
2015
Q4 | $1.12M | Buy |
18,142
+2,200
| +14% | +$139K | ﹤0.01% | 1702 |
|
|
2015
Q3 | $1.1M | Buy |
15,942
+4,742
| +42% | +$329K | ﹤0.01% | 1685 |
|
|
2015
Q2 | $758K | Buy |
11,200
+4,700
| +72% | +$219K | ﹤0.01% | 1822 |
|
|
2015
Q1 | $268K | Buy |
+6,500
| New | +$292K | ﹤0.01% | 2328 |
|
Other funds holding RDUS
UBS AM's RDUS Position: Q3 2022 in Review
UBS AM sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 61,913 shares — an estimated $642K sold.
UBS AM first reported a position in RDUS in Q1 2015 and held it in 30 quarters. The position peaked at $1.22M in Q3 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- UBS AM reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- UBS AM sold 61,913 Radius Health, Inc. shares in Q3 2022, an estimated $642K.
- UBS AM first reported a position in Radius Health, Inc. in Q1 2015 and held it in 30 quarters.
- UBS AM's Radius Health, Inc. position peaked at $1.22M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.